These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 8111809)

  • 1. Economic, clinical, and humanistic outcomes: a planning model for pharmacoeconomic research.
    Kozma CM; Reeder CE; Schulz RM
    Clin Ther; 1993; 15(6):1121-32; discussion 1120. PubMed ID: 8111809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Health outcomes analysis and its applications].
    Carrera-Hueso FJ
    Rev Med Univ Navarra; 1997; 41(4):237-44. PubMed ID: 10420964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic outcomes and contemporary pharmacy practice.
    Reeder CE
    Am Pharm; 1993 Dec; NS33(12 Suppl):S3-6. PubMed ID: 8109541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes research and modeling therapeutic interventions for economic evaluations.
    Langley PC
    Clin Ther; 1994; 16(3):538-52. PubMed ID: 7923319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incorporating clinical outcomes and economic consequences into drug formulary decisions: a practical approach.
    Mather DB; Sullivan SD; Augenstein D; Fullerton DS; Atherly D
    Am J Manag Care; 1999 Mar; 5(3):277-85. PubMed ID: 10351024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relevance of pharmacoeconomic analyses to price and reimbursement decisions in Austria].
    Führlinger S
    Wien Med Wochenschr; 2006 Dec; 156(23-24):612-8. PubMed ID: 17211765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life, satisfaction, and economic outcome measures in studies of prostate cancer screening and treatment, 1990-2000.
    McNaughton-Collins M; Walker-Corkery E; Barry MJ
    J Natl Cancer Inst Monogr; 2004; (33):78-101. PubMed ID: 15504921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacoeconomics in contemporary medicine].
    Czech M
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():16-9. PubMed ID: 15524007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of cost-consequence modeling in outcomes research.
    Stergachis A
    Pharmacotherapy; 1995; 15(5 Pt 2):40S-42S. PubMed ID: 8577629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the clinical and economic outcomes of pharmacy interventions in drug-related problems.
    Westerlund T; Marklund B
    J Clin Pharm Ther; 2009 Jun; 34(3):319-27. PubMed ID: 19646078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A health outcomes framework for assessing health status and quality of life: enhanced data for decision making.
    Erickson P
    J Natl Cancer Inst Monogr; 2004; (33):168-77. PubMed ID: 15504927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficiency versus quality in the NHS, in Portugal: methodologies for evaluation].
    Giraldes Mdo R
    Acta Med Port; 2008; 21(5):397-410. PubMed ID: 19187682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of care: the use of conceptual models to "see the forest and the trees" in planning outcomes studies.
    Camann MA
    Top Health Inf Manage; 2001 Nov; 22(2):10-4. PubMed ID: 11761787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endpoints in medical communication research, proposing a framework of functions and outcomes.
    de Haes H; Bensing J
    Patient Educ Couns; 2009 Mar; 74(3):287-94. PubMed ID: 19150197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview of health-related quality-of-life measures for pediatric patients: application in the assessment of pharmacotherapeutic and pharmacoeconomic outcomes.
    Marra CA; Levine M; McKerrow R; Carleton BC
    Pharmacotherapy; 1996; 16(5):879-88. PubMed ID: 8888083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring and evaluating managed care for children with chronic illnesses and disabilities.
    Newacheck PW; Stein RE; Walker DK; Gortmaker SL; Kuhlthau K; Perrin JM
    Pediatrics; 1996 Nov; 98(5):952-8. PubMed ID: 8909492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the ECHO model in outcomes research and clinical practice improvement.
    Gunter MJ
    Am J Manag Care; 1999 Apr; 5(4 Suppl):S217-24. PubMed ID: 10387542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.